GREY:MRRCF - Post by User
Post by
truestar2on Nov 29, 2017 12:43am
169 Views
Post# 27051855
The McKesson Deal is too Big to Ignore
The McKesson Deal is too Big to IgnoreObviously the financials were expected due to heavy legals from the financing, the NanoLeaf acquisition, McKesson, etc.. I don't think the market can ignore 3000 Pharmacies and the fact that Maricann may be one of the only LPs to be able to sell and maintain a client base at high margins as most others will have to sell to the provinces or retailers at low wholesale pricing. If you can average 6 dollars a gram vs 3 dollars a gram and your all in cost including Opex is 2 dollars a gram your in a whole different league of profitability. I believe Germany will be similar and only those able to maintain their medical clients who are also a much stickier client when referred by their pharmacist and doctor will be highly profitable long term